Overview
CJC-1295 is a synthetic peptide containing 29-30 amino acids designed to mimic the action of the body's natural Growth Hormone Releasing Hormone. It functions by stimulating the anterior pituitary gland to increase the production and secretion of growth hormone, which subsequently raises levels of Insulin-like Growth Factor 1 (IGF-1).
Primarily utilized in research for its anabolic and metabolic properties, it is favored for its ability to enhance muscle growth, accelerate wound healing, and promote fat loss. While it exists in two forms, the version without the Drug Affinity Complex (DAC) is often preferred for maintaining a more natural, pulsatile release of hormones, whereas the DAC version offers a significantly extended duration of action.
Mechanism of action
Acts as a synthetic analog of Growth Hormone Releasing Hormone (GHRH), binding to receptors in the pituitary gland to trigger a pulsatile release of endogenous growth hormone.
Reported benefits
- ▸Stimulates lean muscle mass development and protein synthesis
- ▸Promotes lipolysis and fat metabolism for improved body composition
- ▸Accelerates recovery from intense training and physical injuries
- ▸Supports tissue repair and enhances skeletal bone density
- ▸Improves sleep quality and overall physical vitality
- ▸May improve skin elasticity and anti-aging markers via collagen production
Reported side effects
- ·Flushing of the face and neck
- ·Injection site pain or redness
- ·Water retention (edema)
- ·Headaches or lightheadedness
- ·Increased insulin resistance with long-term use
Often stacked with
IpamorelinGHRP-2GHRP-6BPC-157